← FDA Drug Approvals (Drugs@FDA)

LIPFENDRA

NDA · New Drug Application · Sponsor: MSD · Approved 2026-07-15

Drug application

FDA Application #

NDA220848

Application type

New Drug Application

Brand name

LIPFENDRA

Generic name

LIPFENDRA

Active ingredients

ENLICITIDE DECANOATE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

MSD

Manufacturer

Merck Sharp & Dohme LLC

First approval

2026-07-15

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown